Literature DB >> 24055889

Autophagy paradox and ceramide.

Wenhui Jiang1, Besim Ogretmen2.   

Abstract

Sphingolipid molecules act as bioactive lipid messengers and exert their actions on the regulation of various cellular signaling pathways. Sphingolipids play essential roles in numerous cellular functions, including controlling cell inflammation, proliferation, death, migration, senescence, tumor metastasis and/or autophagy. Dysregulated sphingolipid metabolism has been also implicated in many human cancers. Macroautophagy (referred to here as autophagy) "self-eating" is characterized by nonselective sequestering of cytosolic materials by an isolation membrane, which can be either protective or lethal for cells. Ceramide (Cer), a central molecule of sphingolipid metabolism, has been extensively implicated in the control of autophagy. The increasing evidence suggests that Cer is highly involved in mediating two opposing autophagic pathways, which regulate either cell survival or death, which is referred here as autophagy paradox. However, the underlying mechanism that regulates the autophagy paradox remains unclear. Therefore, this review focuses on recent studies with regard to the regulation of autophagy by Cer and elucidates the roles and mechanisms of action of Cer in controlling autophagy paradox. This article is part of a Special Issue entitled New Frontiers in Sphingolipid Biology.
© 2013. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Cell death; Ceramide; Mitophagy; Sphingolipid

Mesh:

Substances:

Year:  2013        PMID: 24055889      PMCID: PMC3960371          DOI: 10.1016/j.bbalip.2013.09.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  146 in total

Review 1.  The Ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2002-05-13       Impact factor: 5.157

Review 2.  Development by self-digestion: molecular mechanisms and biological functions of autophagy.

Authors:  Beth Levine; Daniel J Klionsky
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

Review 3.  Sphingolipids as therapeutics.

Authors:  Mark Kester; Richard Kolesnick
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

4.  Molecular machinery for non-vesicular trafficking of ceramide.

Authors:  Kentaro Hanada; Keigo Kumagai; Satoshi Yasuda; Yukiko Miura; Miyuki Kawano; Masayoshi Fukasawa; Masahiro Nishijima
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 5.  Autophagy as a cell death and tumor suppressor mechanism.

Authors:  Devrim Gozuacik; Adi Kimchi
Journal:  Oncogene       Date:  2004-04-12       Impact factor: 9.867

Review 6.  LAG1 puts the focus on ceramide signaling.

Authors:  S Michal Jazwinski; Andreas Conzelmann
Journal:  Int J Biochem Cell Biol       Date:  2002-11       Impact factor: 5.085

7.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor.

Authors:  Zhenyu Yue; Shengkan Jin; Chingwen Yang; Arnold J Levine; Nathaniel Heintz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1.

Authors:  Francesca Scarlatti; Chantal Bauvy; Annamaria Ventruti; Giusy Sala; Françoise Cluzeaud; Alain Vandewalle; Riccardo Ghidoni; Patrice Codogno
Journal:  J Biol Chem       Date:  2004-02-17       Impact factor: 5.157

9.  Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells.

Authors:  Krishnan Venkataraman; Christian Riebeling; Jacques Bodennec; Howard Riezman; Jeremy C Allegood; M Cameron Sullards; Alfred H Merrill; Anthony H Futerman
Journal:  J Biol Chem       Date:  2002-06-24       Impact factor: 5.157

10.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

View more
  43 in total

Review 1.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.

Authors:  Stefka Spassieva; Erhard Bieberich
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 2.  Ceramide induced mitophagy and tumor suppression.

Authors:  Mohammed Dany; Besim Ogretmen
Journal:  Biochim Biophys Acta       Date:  2015-01-26

Review 3.  Glycosphingolipids and cell death: one aim, many ways.

Authors:  Carmen Garcia-Ruiz; Albert Morales; José C Fernández-Checa
Journal:  Apoptosis       Date:  2015-05       Impact factor: 4.677

Review 4.  Sphingolipid metabolism in cancer signalling and therapy.

Authors:  Besim Ogretmen
Journal:  Nat Rev Cancer       Date:  2017-11-17       Impact factor: 60.716

5.  TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition.

Authors:  Santiago Lima; Kazuaki Takabe; Jason Newton; Kumar Saurabh; Megan M Young; Andreia Machado Leopoldino; Nitai C Hait; Jane L Roberts; Hong-Gang Wang; Paul Dent; Sheldon Milstien; Laurence Booth; Sarah Spiegel
Journal:  Autophagy       Date:  2018-03-11       Impact factor: 16.016

6.  Detection of WIPI1 mRNA as an indicator of autophagosome formation.

Authors:  Satoshi Tsuyuki; Mei Takabayashi; Manami Kawazu; Kousei Kudo; Akari Watanabe; Yoshiki Nagata; Yusuke Kusama; Kenichi Yoshida
Journal:  Autophagy       Date:  2013-12-23       Impact factor: 16.016

Review 7.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

Review 8.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

Review 9.  Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.

Authors:  Dominic J Gessler; Guangping Gao
Journal:  Methods Mol Biol       Date:  2016

10.  Inhibition of Lysosomal Function Mitigates Protective Mitophagy and Augments Ceramide Nanoliposome-Induced Cell Death in Head and Neck Squamous Cell Carcinoma.

Authors:  Jeremy J P Shaw; Timothy L Boyer; Emily Venner; Patrick J Beck; Tristen Slamowitz; Tara Caste; Alexandra Hickman; Michael H Raymond; Pedro Costa-Pinheiro; Mark J Jameson; Todd E Fox; Mark Kester
Journal:  Mol Cancer Ther       Date:  2020-10-21       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.